DOW, S&P 500 Rally On Gilead COVID-19 Treatment - Forex News by FX Leaders
Gilead

DOW, S&P 500 Rally On Gilead COVID-19 Treatment

Posted Wednesday, April 29, 2020 by
Shain Vernier • 2 min read

Optimism is the word of the day as U.S. stocks bang higher. Through the halfway point of the American session, the DJIA DOW (+610), S&P 500 SPX (+85), and NASDAQ (+300) are all in the green. The catalyst behind the move are reports that Gilead Science is closing in on a COVID-19 treatment. A drug known as Remdesivir is said to be showing promise in clinical trials. Even though details are vague, bidders are jumping into fresh longs on the news.

On the news front, it was another dismal day for the U.S. economic outlook. Here are the key data points:

Event                                                         Actual                  Projected          Previous

GDP (Q1)                                                     -4.8%                     -4.0%                  -4.8%

Core Personal Consumption (Q1)           1.8%                        1.6%                   1.3%

Pending Home Sales (YoY, March)        -16.3%                        NA                     9.4%

Relatively speaking, Core Personal Consumption (Q1) came in strong. However, the big picture is dismal as GDP contracted by -4.8% to open 2020. This is a brutal reading and one that may get worse for Q2. Today’s pullback in GDP is the largest since the Financial Crisis of 2008

These days, negative metrics don’t have much bearing on the markets. Today’s news from Gilead is trumping the worst quarterly GDP showing in a decade. There’s no debate ― COVID-19 is the single largest driver of value in today’s marketplace.

Gilead COVID-19 Clinical Study Sends S&P 500 Higher

The bulls are back on Wall Street, with the June E-mini S&P 500 challenging topside resistance. Although Jerome Powell is due to speak later this afternoon, traders are going long equities in anticipation of further gains.

Gilead
June E-mini S&P 500 Futures (ES), Daily Chart

Overview: For the June E-mini S&P 500, the 62% COVID-19 Fibonacci Retracement (2930.00) is a key level to watch. If we see prices close above this area, a return to 3000.00 may be imminent. 

Ultimately, today’s FED Announcements are going to play a pivotal role in stocks moving forward. Should the tone be exceedingly negative, we may be in for a late-week reversal.

Check out our free forex signals
Follow the top economic events on FX Leaders economic calendar
Trade better, discover more Forex Trading Strategies
Related Articles
Comments
0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments